<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57189">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02127333</url>
  </required_header>
  <id_info>
    <org_study_id>COPD_pO2</org_study_id>
    <nct_id>NCT02127333</nct_id>
  </id_info>
  <brief_title>Role of Oxygen for Vascular Dysfunction</brief_title>
  <official_title>Role of Acute and Chronic Hypoxemia for Vascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik für Kardiologie, Pneumologie und Angiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoxemia may contribute increased morbidity and mortality in COPD patients. We aim to
      characterize the role of acute and chronic hypoxemia for vascular function. For this purpose
      we measure capillary oxygen concentration and  vascular.

      Vascular function is assessed by flow-mediated dilation oft he brachial artery,  forearm
      blood flow and laser doppler perfusion imaging.

      We hypothesize that hypoxemia leads to impaired vascular function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Flow-mediated dilation of the brachial artery</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forearm blood flow</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laser doppler perfusion</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intima-media thickness of the brachial artery</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional diameter change of the brachial artery</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelium-independent vasodilation of the brachial artery</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma nitrite concentration</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <condition>FMD</condition>
  <condition>IMT</condition>
  <condition>Microcirculation</condition>
  <condition>Oxygen Pressure</condition>
  <condition>Carbon Dioxide Pressure</condition>
  <condition>Oxygen Saturation</condition>
  <condition>Forced Expiratory Volume After 1 Second</condition>
  <arm_group>
    <arm_group_label>CAD patients with COPD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CAD patients without COPD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        CAD patients with or without COPD; healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable coronary artery disease

          -  stable chronic obstructive pulmonary disease

        Exclusion Criteria:

          -  acute myocardial infarction within 30 days

          -  acute exazerbated COPD within 30 days

          -  aucte infections

          -  severe acute or chronic renal failure

          -  severe heart failure

          -  atrial fibrillation

          -  severe cardiac arrhythmia

          -  hypotension

          -  active malignant disease

          -  active rheumatic disease

          -  pulmonary hypertension with vasoactive therapy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Disease and Vascular Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malte Kelm, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Cardiology, Pulmonary Disease and Vascular Medicineine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinik-duesseldorf.de/kardiologie</url>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 29, 2014</lastchanged_date>
  <firstreceived_date>April 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Division of Cardiology, Pulmonary Diseases, Vascular Medicine</investigator_title>
  </responsible_party>
  <keyword>chronic obstructive pulmonary disease</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Endothelial function</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
